4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-21-002114
CIK 0001607678other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:37 PM ET
Size
11.2 KB
Accession
0001209191-21-002114
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.00001 per share
2021-01-04+14,667→ 113,819 total - Award
Common Stock, par value $0.00001 per share
2021-01-04+6,667→ 120,486 total - Tax Payment
Common Stock, par value $0.00001 per share
2021-01-04$5.80/sh−2,739$15,886→ 117,747 total - Award
Stock Option (Right to Buy)
2021-01-04+33,000→ 33,000 totalExercise: $5.80From: 2022-01-04Exp: 2031-01-04→ Common Stock (33,000 underlying)
Footnotes (5)
- [F1]Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
- [F2]Includes 1,279 shares acquired on November 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
- [F3]The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 33.33% of which vested on January 4, 2021 upon the achievement of a non-financial performance goal.
- [F4]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to performance restricted stock unit award.
- [F5]25% of the shares subject to the option will vest on each anniversary of the grant date.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:37 PM ET
- Size
- 11.2 KB